Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

globenewswire

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases – NEWSnet – News… as it used to be

More Press Releases

May 2, 2026

Dreamscapes I – Betrayals (101 & 202 Nights) Blends Fiction, Poetry, and Memory in a Haunting Literary Journey

May 2, 2026

The American Institute of Health Care Professionals Offers a Health Care Manager Certification and Education Program

May 2, 2026

Summer Moving Surge 2026: Movers.com Helps Americans Plan Smarter Relocations

May 2, 2026

Spyre Therapeutics Doses First Patient in Pioneering Phase 2 SKYWAY Basket Trial of SPY072, the First Anti-TL1A Antibody Studied in Rheumatic Diseases

Dreamscapes I – Betrayals (101 & 202 Nights) Blends Fiction, Poetry, and Memory in a Haunting Literary Journey

The American Institute of Health Care Professionals Offers a Health Care Manager Certification and Education Program

Summer Moving Surge 2026: Movers.com Helps Americans Plan Smarter Relocations

National Farmer Veteran Coalition Announces 2026 Farmer Veteran Fellowship Fund Awardees